LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Search

Enzo Biochem Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.3M

-2.8M

Pardavimai

-932K

6.4M

Pelnas, tenkantis vienai akcijai

-0.05

Dividendų pajamingumas

125

Pelno marža

-43.58

Darbuotojai

125

EBITDA

-1.8M

-3.1M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

125.00%

2.38%

Kitas uždarbis

2025-10-27

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

16M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Naujienos nuotaikos

By Acuity

70%

30%

342 / 373 reitingas Healthcare

Enzo Biochem Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-21 23:45; UTC

Uždarbis

Li Ning's 1st Half Profit Drops on Higher Tax Expense

2025-08-21 21:29; UTC

Uždarbis

Intuit 4Q Sales Jump 20%, Expects Slower Growth Ahead -- Update

2025-08-21 21:12; UTC

Uždarbis

Workday 2Q Profit Rises With Jump in Revenue

2025-08-21 23:47; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid Caution Over U.S. Econ Outlook -- Market Talk

2025-08-21 23:30; UTC

Uždarbis

Li Ning's 1H Profit Drops on Higher Tax Expense

2025-08-21 23:22; UTC

Uždarbis

Resolute Mining Reiterates 2025 Output, Cost, Capex Guidance

2025-08-21 23:22; UTC

Uždarbis

Resolute Mining Cash, Bullion Worth A$158.7 Million at June 30

2025-08-21 23:21; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-21 23:21; UTC

Rinkos pokalbiai

Intuit Sees Early Traction with AI Agents -- Market Talk

2025-08-21 23:21; UTC

Uždarbis

Resolute Mining Net Cash A$109.9 Million at June 30

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining 1H Revenue A$447.5 Million, Up 31% On-Year

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining 1H Ebitda A$211.1 Million, Up 81% On-Year

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining Won't Pay an Interim Dividend

2025-08-21 23:19; UTC

Uždarbis

Resolute Mining 1H Net Profit A$58.8 Million Vs A$20.9 Million Year Earlier

2025-08-21 22:37; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-21 22:36; UTC

Rinkos pokalbiai

Peter Warren Automotive Moving Into Higher Gear -- Market Talk

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

TSMC Executives Considered Giving Back Chips Act Funds if Government Asked for Equity, Sources Say -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

How Trump Will Decide Which Chips Act Companies Must Give Up Equity -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Commerce Secretary Lutnick Previously Indicated Government May Hold Equity in Semiconductor Companies Other Than Intel -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Administration Might Take Equity in Smaller Companies Receiving Funds Under the Act, Official Says -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Trump Administration Considers Taking Stakes in Companies Receiving Chips Act Money, Source Says -- WSJ

2025-08-21 22:33; UTC

Rinkos pokalbiai

Australia Shares Set to Retreat From Record -- Market Talk

2025-08-21 22:20; UTC

Uždarbis

Regis Resources Cash, Bullion A$517.2 Million at June 30

2025-08-21 22:19; UTC

Uždarbis

Regis Resources FY Ebitda A$780.1 Million Vs A$296.9 Million Year Prior

2025-08-21 22:18; UTC

Uždarbis

Regis Resources FY Revenue A$1.65 Billion, Up 30% On-Year

2025-08-21 22:18; UTC

Uždarbis

Regis Resources to Pay Final Dividend of 5 Australian Cents/Share

2025-08-21 22:17; UTC

Uždarbis

Regis Resources Net Profit A$254.4 Million Vs A$186.0 Million Loss Year Prior

2025-08-21 22:14; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-08-21 22:14; UTC

Rinkos pokalbiai
Uždarbis

Brambles' Stock Surge Suggests Comfort With Guidance -- Market Talk

2025-08-21 21:43; UTC

Karštos akcijos

Intuit, Ross Stores, Workday: Stocks to Watch Afterhours -- WSJ

Akcijų palyginimas

Kainos pokytis

Enzo Biochem Inc Prognozė

Rinkos nuotaikos

By Acuity

342 / 373 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Enzo Biochem Inc

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
help-icon Live chat